droplet microfluidics US Appeals Court Rejects Bio-Rad's 'Zombie' Claims to 10x Genomics' Single-Cell Patents The ruling came as part of a decision to uphold a US International Trade Commission finding that Bio-Rad imported and sold infringing products. 10x Genomics Prices Upsized $440M Public Offering The firm is offering an additional 500,000 shares of Class A stock, bringing the total to 4 million shares, offered at $110 per share. New Methods Boost Scale of Single-Cell Gene Expression Dynamics Studies Premium Labs are finding cheaper, higher-throughput ways to determine the inflection points in gene expression within a particular cell. 10x Genomics Q2 Revenues Fall 23 Percent but Beat Wall Street Estimates The firm's $42.9 million in total revenues and $.41 loss per share for the second quarter both beat the average analyst estimates. 10x Genomics Awarded Exclusive License to Harvard Droplet IP by Massachusetts Court Codefendant 1Cellbio, an instrument maker that had obtained a co-exclusive license to the patents, said it plans to appeal the court's declaration. Jun 2, 2020 10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods Premium May 18, 2020 10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit May 11, 2020 10x Genomics Q1 Revenues Increase 34 Percent Apr 23, 2020 Harvard Spinout 1CellBio Seeks Ideas for Applications of Targeted Single-Cell Tech Premium Mar 26, 2020 GigaMune Hopes to Offer TCR Screens to Pharmas While Scrambling to Keep Expression Libraries Alive Premium Feb 26, 2020 Miroculus Launches Digital Microfluidics Sample Prep System at AGBT, Explores New Applications Premium Feb 18, 2020 10x Genomics Q4 Revenues Grow 49 Percent Feb 14, 2020 Bio-Rad Laboratories Products Indirectly Infringe 10x Genomics Patents, USITC Confirms Jan 22, 2020 10x Genomics Lawsuit Over Exclusivity of Harvard Single-Cell IP License Going to Trial Dec 20, 2019 10x Genomics Shares Rise Following ITC Determination in Patent Infringement Case Nov 25, 2019 Bio-Rad Prevails Over 10x Genomics in German Court on Single-Cell IP Sep 18, 2019 Mission Bio Aims to Grow Single-Cell Genomics Market Share With CNV Analysis, Custom Panels Premium Sep 12, 2019 10x Genomics Prices IPO at $39 Per Share Sep 12, 2019 Bio-Rad Laboratories Sues 10x Genomics Again, Alleging Patent Infringement Aug 26, 2019 10x Genomics Showing 'Little Concern' for Patent Lawsuit Consequences, Customers Say Premium Aug 15, 2019 HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery Premium Jul 15, 2019 Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts Jul 10, 2019 Mission Bio, Novogene Announce China Distribution Deal Jan 10, 2019 Samplix Receives €1.9M From European Union Jun 13, 2018 Dolomite Bio Aims to Develop Flexible, Streamlined Single-Cell Sequencing Applications Premium Load More Breaking News GWAS Reveals New Loci Linked to Brain White Matter Microstructure Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration New ALS Risk Gene Suggests Role for Apoptosis Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research Danaher to Acquire Aldevron for $9.6B OncoDNA, Institut Jules Bordet Partner on Central Nervous System Metastasis Study The Scan Not as High as Hoped The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19. Finding Freshwater DNA A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports. Rise in Payments Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws. Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.